Mettler-Toledo International Inc. (NYSE:MTD) Receives $1,304.25 Average Price Target from Analysts

Mettler-Toledo International Inc. (NYSE:MTD - Get Free Report) has received an average rating of "Hold" from the nine research firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $1,304.25.

A number of brokerages have recently issued reports on MTD. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research report on Monday, April 7th. Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a report on Tuesday, April 22nd. Wells Fargo & Company reduced their price target on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Finally, Evercore ISI lifted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a report on Monday, February 10th.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock traded down $16.20 during trading hours on Friday, reaching $1,049.03. The stock had a trading volume of 10,020 shares, compared to its average volume of 143,467. The company has a market cap of $21.86 billion, a price-to-earnings ratio of 25.88, a PEG ratio of 3.30 and a beta of 1.28. The business's 50 day moving average price is $1,150.43 and its 200-day moving average price is $1,239.91. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. On average, sell-side analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, insider Christian Magloth sold 790 shares of the firm's stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 600 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the transaction, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. This represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by corporate insiders.

Institutional Trading of Mettler-Toledo International

Institutional investors have recently modified their holdings of the company. Walter Public Investments Inc. raised its stake in shares of Mettler-Toledo International by 5.6% during the first quarter. Walter Public Investments Inc. now owns 7,841 shares of the medical instruments supplier's stock valued at $9,260,000 after purchasing an additional 416 shares during the period. Brown Advisory Inc. raised its holdings in Mettler-Toledo International by 3.3% in the first quarter. Brown Advisory Inc. now owns 2,387 shares of the medical instruments supplier's stock valued at $2,819,000 after acquiring an additional 77 shares in the last quarter. Crossmark Global Holdings Inc. raised its stake in shares of Mettler-Toledo International by 10.3% in the 1st quarter. Crossmark Global Holdings Inc. now owns 3,793 shares of the medical instruments supplier's stock valued at $4,479,000 after purchasing an additional 355 shares in the last quarter. Pacific Point Advisors LLC grew its holdings in shares of Mettler-Toledo International by 9.6% during the first quarter. Pacific Point Advisors LLC now owns 1,073 shares of the medical instruments supplier's stock valued at $1,267,000 after purchasing an additional 94 shares during the last quarter. Finally, TD Private Client Wealth LLC lifted its holdings in Mettler-Toledo International by 5.4% in the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock valued at $253,000 after acquiring an additional 11 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.